PGR and breast cancer: Results from recent clinical trials with aromatase inhibitors, agents that suppress estrogen synthesis through peripheral aromatization, in postmenopausal women with ER- or progesterone-receptor-positive breast cancer reinforce the importance of estrogen in breast-cancer growth.